Today: 17 May 2026
Opendoor stock slips in early trade as mortgage-rate outlook stays cloudy ahead of Feb. 19 results
2 February 2026
2 mins read

Opendoor stock slips in early trade as mortgage-rate outlook stays cloudy ahead of Feb. 19 results

New York, February 2, 2026, 10:47 (EST) — Regular session

  • Opendoor shares dipped roughly 1.6%, hitting $5.07 in early trading.
  • After the Fed paused on interest rates, mortgage rates dipped slightly, though the 30-year fixed remains just over 6%.
  • Opendoor’s quarterly report and video event on Feb. 19 will be the next key focus for investors.

Opendoor Technologies shares slipped 1.6% to $5.07 in Monday’s morning session, down from a Friday close of $5.15. The stock fluctuated between $4.97 and $5.11, with around 11.7 million shares traded.

The broader market remained unsettled as the pullback unfolded. The Dow climbed, but the Nasdaq slipped after CME Group boosted margin requirements on precious metals. Investors also weighed President Donald Trump’s pick of Kevin Warsh to head the Federal Reserve.

For Opendoor, the immediate focus remains on interest rates. Changes in how the market prices mortgage costs often trigger swift moves in housing-related stocks—even when there’s no fresh company news.

National mortgage rates edged mostly lower from last week, with the average 30-year fixed rate holding at 6.16%, according to Bankrate. Anthony Kellum of Kellum Mortgage said, “I don’t believe the data is compelling enough to prompt an immediate shift in policy.” The Mortgage Bankers Association expects rates to remain between 6% and 6.5%. Its chief economist, Mike Fratantoni, added that the Fed meeting “does not change our forecast for mortgage rates.” Bankrate

Economic data kept attention focused. The Institute for Supply Management reported its January manufacturing PMI climbed to 52.6, marking its first reading above 50 in a year—a sign of expansion.

Opendoor operates an e-commerce platform focused on residential real estate. The company purchases homes straight from sellers and flips them, following an “iBuyer” approach. It also provides listing and marketplace services. Reuters

Shares of other housing-related firms edged higher: Rocket Companies jumped 5.4%, while Zillow Group climbed roughly 1.1% in early trading.

Opendoor’s next major event is set for Feb. 19, when it will release its fourth-quarter and full-year 2025 results. Instead of a standard earnings call, management plans a “Financial Open House” livestream that will feature a live Q&A session for shareholders using Robinhood’s Say Technologies platform. GlobeNewswire

Investors are focused on whether the company can turn inventory fast with spring right around the corner, and if funding costs stay below resale price growth. For Opendoor, it’s the mechanics — turns, spreads, cash flow — that usually dictate the tape.

But the model can become more restrictive if homes linger on the market. In its annual filing, the company reported holding roughly $1.9 billion in non-recourse asset-backed loans as of Dec. 31, 2024. It also noted that borrowing capacity against a property may drop after about six months in inventory and could hit zero after 12 months under certain loan agreements.

Opendoor’s stock has climbed roughly 13% so far this year, based on the latest figures.

Opendoor’s next key date is Feb. 19, when it releases earnings and holds a video event. This will be the company’s first chance this quarter to present a full picture of demand, inventory, and financing in a single update.

Stock Market Today

  • SpaceX Shareholders Approve 5-for-1 Stock Split
    May 16, 2026, 6:32 PM EDT. SpaceX shareholders have approved a 5-for-1 stock split, according to Bloomberg News citing people familiar with the matter. The split, recommended by the company's board, will increase the number of shares outstanding by a factor of five, making shares more accessible to investors. This move typically aims to enhance liquidity and broaden the shareholder base.

Latest articles

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
Zeta Global Stock Rises as Snowflake Deal Comes Ahead of Key Vote

Zeta Global Stock Rises as Snowflake Deal Comes Ahead of Key Vote

17 May 2026
Zeta Global shares closed at $17.19, up 3.68% Friday, outperforming major indexes after joining Snowflake’s Open Semantic Interchange data initiative. The stock retreated to $17.14 after hours. Zeta will present at the JPM 2026 Global Technology, Media and Communications Conference on Monday. First-quarter revenue jumped 50% to $396 million, prompting a full-year guidance raise.
Johnson & Johnson Stock Fell Friday — The Week-Ahead Setup Investors Should Watch

Johnson & Johnson Stock Fell Friday — The Week-Ahead Setup Investors Should Watch

16 May 2026
Johnson & Johnson shares fell 1.77% to $226.71 Friday amid a broad market selloff but ended the week up about 2.4%. The NYSE is closed for the weekend, with trading set to resume Monday. Investors are watching upcoming neuropsychiatry data presentations and the global launch of the Shockwave C2 Aero Coronary IVL Catheter. No new earnings report is expected next week.
Twist Bioscience stock jumps as record quarterly revenue lifts 2026 outlook — what investors watch next
Previous Story

Twist Bioscience stock jumps as record quarterly revenue lifts 2026 outlook — what investors watch next

Freeport-McMoRan stock steadies after wild swing as copper tumbles — what to watch next
Next Story

Freeport-McMoRan stock steadies after wild swing as copper tumbles — what to watch next

Go toTop